RxDoctor Payments Data

Kimberly Giberga

Family · San Antonio, TXNPI 1114250651

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $22,000 of the $35,919 with a category attached, or 61.2%. AbbVie accounts for 65.0% of it on its own, with 40 other manufacturers making up the rest. 2025 is the largest year on record at $27,408, more than ten times the $733 reported in 2021. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,919in general payments, 2019–2025

Across 277 payments — averaging $129.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$23K
  • Johnson & Johnson$2K
  • Axsome Therapeutics, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$986
  • Teva Pharmaceuticals USA, Inc.$666
  • Novo Nordisk$631
  • plus $7K from 35 others

What the payments were for

  • Speaking & faculty fees$22,00061%
  • Travel & lodging$9603%
  • Food & beverage$12,93536%
  • Education$240%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,919 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Other family in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →